← Back to Directory

Lakewood-Amedex Biotherapeutics, Inc. (LABT) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Lakewood-Amedex Biotherapeutics, Inc. (LABT).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Details

Price & Market Data

Price: $3.16

Daily Change: $0.00 / 0.00%

Daily Range: $3.10 - $3.32

Market Cap: $46,111,580

Daily Volume: 224,529

Performance Metrics

1 Week: 3.87%

1 Month: -59.91%

3 Months: -59.91%

6 Months: -59.91%

1 Year: -59.91%

YTD: -62.77%

About Lakewood-Amedex Biotherapeutics, Inc. (LABT)

Key metrics for Lakewood-Amedex Biotherapeutics, Inc. (LABT). Current price: 3.16, daily change: $0.00 / 0.00%. Market cap: 46,111,580. Performance across all periods for quick analysis.

Company Details

Employees: 5

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin® class, a novel class of antimicrobial agents that fight infections by disrupting microbial membranes. It develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers. Lakewood-Amedex Biotherapeutics, Inc. was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June, 2025. The company was incorporated in 2006 and is headquartered in University Park, Florida.

Selected stocks

Accendra Health, Inc. (ACH)

Nexera Technologies Ltd (NEXR)

Tuya Inc. (TUYA)

OKYO Pharma Limited (OKYO)

GlucoTrack, Inc. (GCTK)